"Economic relevance" in pharmacoeconomic studies.

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies

Invasive aspergillosis is a life-threatening fungal infection predominately affecting immunocompromised individuals. The incidence of inpatient-treated aspergillosis cases in the US is estimated to be between 3.02 and 3.80 per 10,000 hospitalized patients. The estimated difference in hospital costs of patients with an aspergillosis infection is US$36,867 to US$59,356 higher than those of patien...

متن کامل

Guidelines for Economic Evaluations in Italy: Recommendations from the Italian Group of Pharmacoeconomic Studies

Since 1997, in order for a new drug to obtain its price and reimbursement in Italy, the negotiation between authorities and the pharmaceutical industry must include an economic evaluation. The economic evaluation study leads to price and reimbursement negotiations together with such other requirements as the price of the new drug in other countries, the impact on the domestic market in terms of...

متن کامل

Pharmacoeconomic studies in Nepal: the need of the hour

Pharmacoeconomics is a rapidly expanding field with interests from the whole gamut of health-related personnel, spanning from hospital administrators to policy makers (Drummond et al., 2003). It incorporates various analytical techniques that deal with costs and outcomes of pharmaceutical interventions employed in prevention, diagnosis, treatment and management of diseases. Pharmacoeconomic eva...

متن کامل

Panel 2: methodological issues in conducting pharmacoeconomic evaluations--modeling studies.

The primary purpose of modeling is to inform the decision-making process [1,2]. One considerable benefit of model formalization is that the uncertainties and assumptions in this process are made explicit and transparent. To estimate costs and outcomes, existing data are frequently insufficient to allow optimal healthcare decision-making. Each type of data (retrospective, prospective, meta-analy...

متن کامل

Panel 1: methodological issues in pharmacoeconomic evaluations--clinical studies.

1 The Institute for Research & Education, HealthSystems Minnesota, Minneapolis, MN, 2 Merck Medco Managed Care, LLC, Montvale, NJ, 3 Center for Outcomes & Effectiveness Research, Agency for Health Care Policy and Research, Rockville, MD, 4 Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 5 Focus Managed Research Inc., Worcester, MA, 6 SmithKline Beecham, Collegeville, PA, 7 Stanford U...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ

سال: 1993

ISSN: 0959-8138,1468-5833

DOI: 10.1136/bmj.306.6870.147-a